Sincere Capital is a venture capital firm that invests in early and late stages.
Sincere Capital, which was founded by senior investment specialists and had completed all the necessary regulatory registration procedures with Asset Management Association of China, mainly engages in investing in the fields of technology innovation and State-Owned Enterprises (SOE) reforms.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Apr 29, 2020
Mabwell Biotech
|
Series A | $278.50M | Biopharma | — |